The Affordable Care Act amends the Public Health Service Act to create an abbreviated licensure pathway for biological products that are demonstrated to be “biosimilar” to or “interchangeable” with an FDA-licensed biological product. This pathway is provided in the...
Automated monitoring of health data sources to identify trends that may indicate an emerging epidemic, whether naturally occurring or as a result of bioterrorism.